These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11277527)

  • 1. Synthesis and use of FSCPX, an irreversible adenosine A1 antagonist, as a 'receptor knock-down' tool.
    van Muijlwijk-Koezen JE; Timmerman H; van der Sluis RP; van de Stolpe AC; Menge WM; Beukers MW; van der Graaf PH; de Groote M; IJzerman AP
    Bioorg Med Chem Lett; 2001 Mar; 11(6):815-8. PubMed ID: 11277527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel irreversible antagonist of the A1-adenosine receptor.
    Srinivas M; Shryock JC; Scammells PJ; Ruble J; Baker SP; Belardinelli L
    Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New irreversible adenosine A(1) antagonists based on FSCPX.
    Beauglehole AR; Baker SP; Scammells PJ
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3179-82. PubMed ID: 12372528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Advanced In Silico Modelling of the Interaction between FSCPX, an Irreversible A
    Szabo AM; Erdei T; Viczjan G; Kiss R; Zsuga J; Papp C; Pinter A; Juhasz B; Szilvassy Z; Gesztelyi R
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31212849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor.
    Beauglehole AR; Baker SP; Scammells PJ
    J Med Chem; 2000 Dec; 43(26):4973-80. PubMed ID: 11150167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors.
    Scammells PJ; Baker SP; Belardinelli L; Olsson RA
    J Med Chem; 1994 Aug; 37(17):2704-12. PubMed ID: 8064798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A
    Viczjan G; Erdei T; Ovari I; Lampe N; Szekeres R; Bombicz M; Takacs B; Szilagyi A; Zsuga J; Szilvassy Z; Juhasz B; Gesztelyi R
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The surmountable effect of FSCPX, an irreversible A(1) adenosine receptor antagonist, on the negative inotropic action of A(1) adenosine receptor full agonists in isolated guinea pig left atria.
    Gesztelyi R; Kiss Z; Wachal Z; Juhasz B; Bombicz M; Csepanyi E; Pak K; Zsuga J; Papp C; Galajda Z; Branzaniuc K; Porszasz R; Szentmiklosi AJ; Tosaki A
    Arch Pharm Res; 2013 Mar; 36(3):293-305. PubMed ID: 23456693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Furchgott's method to determine agonist-dependent A1-adenosine receptor reserve in guinea-pig atrium.
    Morey TE; Belardinelli L; Dennis DM
    Br J Pharmacol; 1998 Apr; 123(7):1425-33. PubMed ID: 9579739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FSCPX, a Chemical Widely Used as an Irreversible A₁ Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium.
    Erdei T; Szabo AM; Lampe N; Szabo K; Kiss R; Zsuga J; Papp C; Pinter A; Szentmiklosi AJ; Szilvassy Z; Juhasz B; Gesztelyi R
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30200192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists.
    Grahner B; Winiwarter S; Lanzner W; Müller CE
    J Med Chem; 1994 May; 37(10):1526-34. PubMed ID: 8182711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential A1 adenosine receptor reserve for two actions of adenosine on guinea pig atrial myocytes.
    Srinivas M; Shryock JC; Dennis DM; Baker SP; Belardinelli L
    Mol Pharmacol; 1997 Oct; 52(4):683-91. PubMed ID: 9380032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
    Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
    J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX): a useful tool for pharmacologists and physiologists?
    Coates J; Sheehan MJ; Strong P
    Gen Pharmacol; 1994 May; 25(3):387-94. PubMed ID: 7926579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists.
    Peet NP; Lentz NL; Dudley MW; Ogden AM; McCarty DR; Racke MM
    J Med Chem; 1993 Dec; 36(25):4015-20. PubMed ID: 8258823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of A1 adenosine receptor ligand [3H]8-cyclopentyl-1,3-dipropylxanthine in coronary smooth muscle.
    Hussain T; Mustafa SJ
    Circ Res; 1995 Jul; 77(1):194-8. PubMed ID: 7788877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life.
    Zsuga J; Erdei T; Szabó K; Lampe N; Papp C; Pinter A; Szentmiklosi AJ; Juhasz B; Szilvássy Z; Gesztelyi R
    Molecules; 2017 May; 22(5):. PubMed ID: 28534854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular simulation of 8-styrylxanthines.
    Mager PP; Reinhardt R; Richter M; Walther H; Rockel B
    Drug Des Discov; 1995 Nov; 13(2):89-107. PubMed ID: 8872454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes.
    Peakman MC; Hill SJ
    Br J Pharmacol; 1994 Jan; 111(1):191-8. PubMed ID: 8012696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.